JP2018517151A5 - - Google Patents

Download PDF

Info

Publication number
JP2018517151A5
JP2018517151A5 JP2018511342A JP2018511342A JP2018517151A5 JP 2018517151 A5 JP2018517151 A5 JP 2018517151A5 JP 2018511342 A JP2018511342 A JP 2018511342A JP 2018511342 A JP2018511342 A JP 2018511342A JP 2018517151 A5 JP2018517151 A5 JP 2018517151A5
Authority
JP
Japan
Prior art keywords
filamin
acetylglucosamine
sulfatase
subject
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511342A
Other languages
English (en)
Japanese (ja)
Other versions
JP6663000B2 (ja
JP2018517151A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/032077 external-priority patent/WO2016183310A1/en
Publication of JP2018517151A publication Critical patent/JP2018517151A/ja
Publication of JP2018517151A5 publication Critical patent/JP2018517151A5/ja
Application granted granted Critical
Publication of JP6663000B2 publication Critical patent/JP6663000B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511342A 2015-05-12 2016-05-12 関節リウマチの診断のための自己抗原 Active JP6663000B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562160320P 2015-05-12 2015-05-12
US62/160,320 2015-05-12
US201562162295P 2015-05-15 2015-05-15
US62/162,295 2015-05-15
PCT/US2016/032077 WO2016183310A1 (en) 2015-05-12 2016-05-12 Autoantigens for diagnosis of rheumatoid arthritis

Publications (3)

Publication Number Publication Date
JP2018517151A JP2018517151A (ja) 2018-06-28
JP2018517151A5 true JP2018517151A5 (enExample) 2019-06-13
JP6663000B2 JP6663000B2 (ja) 2020-03-11

Family

ID=57248470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018511342A Active JP6663000B2 (ja) 2015-05-12 2016-05-12 関節リウマチの診断のための自己抗原

Country Status (6)

Country Link
US (1) US10429379B2 (enExample)
EP (1) EP3294901B1 (enExample)
JP (1) JP6663000B2 (enExample)
AU (1) AU2016261939A1 (enExample)
CA (1) CA2985637A1 (enExample)
WO (1) WO2016183310A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10908159B2 (en) 2016-06-07 2021-02-02 The General Hospital Corporation Identification of a T cell epitope of Prevotella copri that induces T cell responses in patients with Rheumatoid arthritis
US20180280503A1 (en) 2017-04-04 2018-10-04 The Johns Hopkins University Anti-pad2 antibody for treating and evaluating rheumatoid arthritis
JP7202010B2 (ja) * 2017-07-06 2023-01-11 国立大学法人 筑波大学 関節リウマチ診断薬
US20210388345A1 (en) * 2018-10-22 2021-12-16 Roche Sequencing Solutions, Inc. Profiling of rheumatoid arthritis autoantibody repertoire and peptide classifiers therefor

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1105734B (it) * 1977-07-14 1985-11-04 Syva Co Prova di legame di competizione di antienzima omogeneo
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
US5248595A (en) 1991-10-08 1993-09-28 Eastman Kodak Company Wash composition, test kit and method for determination of microorganisms associated with periodontal diseases
US5750356A (en) * 1996-05-31 1998-05-12 Anergen, Inc. Method for monitoring T cell reactivity
AU2002230997A1 (en) 2000-12-15 2002-06-24 Genetics Institute, Llc Methods and compositions for diagnosing and treating rheumatoid arthritis
US20050130117A1 (en) * 2001-10-03 2005-06-16 Davis Cong L. Modulators of lymphocyte activation and migration
US9493539B2 (en) 2003-03-07 2016-11-15 London Health Sciences Centre Research Inc. Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseases
DE602004030586D1 (de) 2003-09-15 2011-01-27 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
WO2005064307A2 (en) 2003-12-23 2005-07-14 Roche Diagnostics Gmbh Method of assessing rheumatoid arthritis by measuring anti-ccp and interleukin 6
ES2314621T3 (es) 2004-02-27 2009-03-16 F. Hoffmann-La Roche Ag Procedimiento de evaluacion de la artritis reumotoidea, mediante la medicion de anti-ccp y amiloide a serico.
WO2006008183A1 (en) 2004-07-23 2006-01-26 Novartis Ag Biomarkers for rheumatoid arthritis (ra)
US20070148704A1 (en) 2005-10-06 2007-06-28 Ursula Klause Anti-CCPand antinuclear antibodies in diagnosis of rheumatoid arthritis
IN2012DN02485A (enExample) 2009-09-03 2015-08-28 Hoffmann La Roche
WO2012040264A2 (en) * 2010-09-21 2012-03-29 The General Hospital Corporation Diagnostic tests for immune reactivity with human endothelial cell growth factor
AU2011372528C1 (en) * 2011-07-01 2017-01-19 Inova Diagnostics, Inc. Method for increasing specificity of diagnostic tests for autoimmune diseases
KR20160014584A (ko) * 2013-03-13 2016-02-11 코어 파마슈티칼스 디벨롭먼트 컴퍼니 염증 치료용 면역-변형된 입자
US10908159B2 (en) 2016-06-07 2021-02-02 The General Hospital Corporation Identification of a T cell epitope of Prevotella copri that induces T cell responses in patients with Rheumatoid arthritis

Similar Documents

Publication Publication Date Title
Mahler et al. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights
Poole et al. Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments
He et al. Proteomics‐based identification of HSP60 as a tumor‐associated antigen in colorectal cancer
US9683031B2 (en) Biomarkers for rheumatoid arthritis
Szarka et al. Recognition of new citrulline‐containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients
JP2018517151A5 (enExample)
Trier et al. Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis
AU2016353453A1 (en) Methods and compositions for assessing antibody specificities
JP2017532544A5 (enExample)
Rytkönen-Nissinen et al. IgE reactivity of the dog lipocalin allergen Can f 4 and the development of a sandwich ELISA for its quantification
JP2021006811A (ja) 魚介類アレルギーの診断の方法及び製品
RU2017114626A (ru) Антитело, связывающее линейный эпитоп человеческого р53, и его применение в диагностике
AU2006246342B2 (en) Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/ diagnostic use
AU2012257781A1 (en) Method for the diagnosis of early Rheumatoid Arthritis
CN104086640A (zh) 一种检测肿瘤免疫标志物birc5自身抗体氨基酸序列及应用
Saito et al. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis
CN116239684A (zh) 针对人钙网蛋白的兔单克隆抗体及其制备方法和应用
EP2592419A1 (en) Method for detection of infection with human cytomegalovirus
Wang et al. Keratin 8 is a novel autoantigen of rheumatoid arthritis
KR20170093141A (ko) 데옥시하이푸신·신타제 유전자를 지표로서 사용하는 동맥 경화 및 암의 검출 방법
AU2016261939A1 (en) Autoantigens for diagnosis of rheumatoid arthritis
Mahler et al. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
RU2013158627A (ru) Антитела к рецептору человеческого эритропоэтина и способы их применения
Auger et al. HLA-DRB1* 0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis
JP2014162772A (ja) 抗シトルリン化タンパクヒトIgG抗体およびその用途